HeartSciences Inc (HSCS) Q1 2026: Hscs

Executive Summary

HeartSciences Inc (HSCS) reported QQ1 2026 results with modest revenue of USD 1.9 million, producing a gross profit of USD 1.14 million and a robust gross margin of 60.0%. However, the quarter was dominated by extraordinary research and development expenditure (USD 997.206 million) and substantial selling, general, and administrative spending (USD 878.053 million), which together drove operating expenses to USD 1.875 billion and yielded a substantial operating loss. Net income for the period stood at USD -2.055 million, with an EPS of USD -1.58, underscoring a pronounced burn driven by pre-commercial investment in AI-enabled ECG technology and cloud-based platforms.

Key Performance Indicators

Revenue

1.90M

QoQ: N/A | YoY:N/A

Gross Profit

1.14M

60.00% margin

QoQ: N/A | YoY:12 489.96%

Operating Income

-1.87B

QoQ: 20.97% | YoY:-99 598.32%

Net Income

-2.05M

QoQ: 99.92% | YoY:-11.31%

EPS

-1.58

QoQ: 99.94% | YoY:42.12%

Revenue Trend

Margin Analysis

Key Insights

Financial Highlights

Revenue: USD 1,900,000; Cost of Revenue: USD 760,000; Gross Profit: USD 1,140,000; Gross Margin: 60.0%; Research and Development Expenses: USD 997,206,000; Selling, General and Administrative Expenses: USD 878,053,000; Operating Expenses: USD 1,875,259,000; EBITDA: USD -1,839,631; EBITDA Margin: -96.8%; Operating Income: USD -1,874,119,000; Operating Income Margin: -986.38%; Total Other Income/Expenses: USD -180,875,000; Income Before Tax: USD -2,054,994,000; Net Income: USD -2,054,994; Net Income Margin: -1.08%; Earnings Per Share (EPS): USD -1.58; Weighted Avg Shares: 1,303,532; Cash Flow from Operations: USD -1,953,367,000; Cash Flow from Financing: USD 3,648,314,000; Cash Flow from Investing: USD -814,000; Net Change in Cash: USD 1,694,133,000; Cash at End of Period: USD 2,792,231,000.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	1.90M	N/A	N/A
Gross Profit	1.14M	12 489.96%	N/A
Operating Income	-1.87B	-99 598.32%	20.97%
Net Income	-2.05M	-11.31%	99.92%
EPS	-1.58	42.12%	99.94%

Key Financial Ratios

Net Income vs. Revenue

Expense Breakdown

Competitive Position

Company	Gross Margin	Operating Margin	Return on Equity	P/E Ratio
HSCS Focus	60.00%	N/A	N/A	N/A
BBLG	0.00%	0.00%	-34.90%	-62.60%
NAOV	72.10%	-61.70%	-16.80%	-10.33%
BJDX	0.00%	0.00%	-48.20%	-27.70%
VVOS	50.00%	-1.24%	-87.70%	-1.59%

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q1 2026	1.90	-1.58	+0.0%	View
Q3 2025	0.00	-2,572.16	+0.0%	View
Q2 2025	0.00	-2.27	+0.0%	View
Q1 2025	0.00	-2.64	+0.0%	View
Q4 2024	0.00	-2.73	+0.0%	View

HeartSciences Inc (HSCS) Q1 2026 Earnings Report

Earnings Highlights

HeartSciences Inc (HSCS) QQ1 2026 Results – AI-Enhanced ECG Platform Advancement Amid Heavy R&D Investment

Executive Summary

Key Performance Indicators

Revenue

Gross Profit

Operating Income

Net Income

EPS

Revenue Trend

Margin Analysis

Key Insights

Financial Highlights

Income Statement

Key Financial Ratios

Net Income vs. Revenue

Expense Breakdown

Management Commentary

Forward Guidance

Competitive Position

Gross Profit Margin

Operating Profit Margin

Return on Equity

P/E Ratio Comparison

Investment Outlook

Key Investment Factors

Growth Potential

Profitability Risk

Financial Position

SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Historical Earnings Comparison

HeartSciences Inc (HSCS) Q1 2026 Earnings Report

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue

Gross Profit

Operating Income

Net Income

EPS

Revenue Trend

Margin Analysis

Key Insights

Financial Highlights

Income Statement

Key Financial Ratios

Net Income vs. Revenue

Expense Breakdown

Management Commentary

Forward Guidance

Competitive Position

Gross Profit Margin

Operating Profit Margin

Return on Equity

P/E Ratio Comparison

Investment Outlook

Key Investment Factors

Growth Potential

Profitability Risk

Financial Position

SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Historical Earnings Comparison

More HSCS Quarterly Reports

HSCS

HSCS

HSCS

HSCS

Q1 2026 Reports in Healthcare Sector

Related Financial Data

Sector Analysis: Healthcare

HSCS Full Profile

HSCS Financial Statements

Earnings Calendar